Log in

Relevant bibliographies by topics / Metastatic carcinoma / Dissertations / Theses

To see the other types of publications on this topic, follow the link: Metastatic carcinoma.

Dissertations / Theses on the topic 'Metastatic carcinoma'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Metastatic carcinoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Nordman, Ina IC Clinical School St Vincent's Hospital Faculty of Medicine UNSW. "Surrogate endpoints of survival in metastatic carcinoma." Publisher:University of New South Wales. Clinical School - St Vincent's Hospital, 2008. http://handle.unsw.edu.au/1959.4/42791.

Full text

Abstract:

In most randomised controlled trials (RCTs), a large number of patients need to be followed over many years, for the clinical benefit of the drug to be accurately quantified (1). Using an early proxy, or a surrogate endpoint, in place of the direct endpoint of overall survival (OS) could theoretically shorten the duration of RCTs and minimise the exposure of patients to ineffective or toxic treatments (2, 3). This thesis examined the relationship between surrogate endpoints and OS in metastatic colorectal cancer (CRC), advanced non-small cell lung cancer (NSCLC) and metastatic breast cancer (M

APA, Harvard, Vancouver, ISO, and other styles

2

Lee, Yee-ki Carol. "Effect of dietary fatty acids on metastatic hepatocellular carcinoma /." Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/hkuto/record/B39707349.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Malek, Joël. "Genetic alterations of the metastatic lesions in ovarian carcinoma." Thesis, Paris 11, 2011. http://www.theses.fr/2011PA11T109.

Full text

Abstract:

Le cancer de l’ovaire est le cancer gynécologique avec la plus grande mortalité due à un diagnostique tardif au stade de maladie extensive péritonéale. Malgré les progrès de la chirurgie radicale et de la chimiothérapie les récurrences abdominales demeurent la cause la plus fréquente de mortalité. Il existe peu d’études de la maladie métastatique péritonéale. Notre hypothèse de travail est que les différences entre la maladie métastatique et la tumeur primaire sont primordiales dans la survenue d’une maladie résiduelle ou récurrente. Nous avons utilisé une approche exhaustive comprenant des ét

APA, Harvard, Vancouver, ISO, and other styles

4

Uva, V. "FOXP3 EXPRESSION IN BREAST CARCINOMA CELLS AND METASTATIC SPREAD." Doctoral thesis, Università degli Studi di Milano, 2014. http://hdl.handle.net/2434/229557.

Full text

Abstract:

Forkhead box P3 (FOXP3), a gene member of the forkhead/winged-helix family of transcription regulators, is implicated in regulating immune system development and function. This gene has been found to be of crucial importance for the generation of CD4+CD25+ regulatory T cells (Tregs). Tregs express both the full-length FOXP3 and Δ2FOXP3 natural splice variant. In addition to its expression in the lymphocyte lineage, studies have recently described FOXP3 expression in non-hematopoietic-derived cells, including cancerous or normal epithelial cells of multiple lineages and origins. The role of FO

APA, Harvard, Vancouver, ISO, and other styles

5

Bartrolí, Comellas Mariona. "Prognostic markers and therapeutic targets for metastatic renal cell carcinoma." Doctoral thesis, Universitat de Barcelona, 2018. http://hdl.handle.net/10803/664198.

Full text

Abstract:

Targeting cancer metastasis has gained considerable importance in the recent years when aiming to increase patients’ overall survival. In Renal Cell Carcinoma (RCC), the discovery of metastatic biomarkers and targets is still required, as most patients present metastatic disease at the time of diagnosis. Therefore, the aim of this thesis is the discovery of new biomarkers and targets of metastatic RCC using two variants of a patient-derived orthoxenograft (PDOX) animal model of clear cell RCC (ccRCC). Indeed, PDOX models have recently gained significant relevance for studying the progressio

APA, Harvard, Vancouver, ISO, and other styles

6

Pilborough, Alice Elizabeth. "Tumour-stromal crosstalk in metastatic lymph nodes of oral squamous cell carcinoma." Thesis, University of Sheffield, 2018. http://etheses.whiterose.ac.uk/22053/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Kerr, Ian Balfour. "A study of metastasis in colorectal carcinoma using DNA recombinant and molecular hybridisation techniques." Thesis, University of Edinburgh, 1989. http://hdl.handle.net/1842/19010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Ho, Chi-lai, and 何志禮. "Dual-tracer positron emission tomography in the evaluation ofprimary & metastatic hepatocellular carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B45205024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Griffin, Ryan D. "MULTISPECTRAL CO-OCCURRENCE ANALYSIS FOR AUTOMATED TUMOR DETECTION IN METASTATIC MEDULLARY THYROID CARCINOMA." The Ohio State University, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=osu1285101309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Okuno, Tomoko. "Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma." Kyoto University, 2011. http://hdl.handle.net/2433/142555.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

MARCAZZAN, SABRINA. "DEVELOPMENT OF MOUSE MODELS OF ORAL SQUAMOUS CELL CARCINOMA (OSCC) METASTASIS FOR THE EVALUATION OF EMERGING ANTI-METASTATIC NANOMEDICINE DRUGS." Doctoral thesis, Università degli Studi di Milano, 2018. http://hdl.handle.net/2434/603863.

Full text

Abstract:

Oral Squamous Cell Carcinoma (OSCC) is included in the Head and Neck Squamous Cell Carcinoma (HNSCC) group, which is the sixth most common cancer diagnosed worldwide. While the locoregional control has been increased thanks to the combination therapy, the incidence of distant metastasis is increasing. Nanomedicine therapies have been clinically approved for the treatment of several types of cancers and were used in few clinical trials on HNSCC patients. However, the efficacy of nanomedicine therapies was limited, especially for the treatment of metastatic OSCC. In the preclinical setting, more

APA, Harvard, Vancouver, ISO, and other styles

12

Swofford, Brenen P., and Tomislav Dragovich. "Durable and Complete Response to Herceptin Monotherapy in Patients with Metastatic Gastroesophageal Cancer." KARGER, 2017. http://hdl.handle.net/10150/626424.

Full text

Abstract:

Gastroesophageal cancer is the sixth leading cause of cancer-related death worldwide. The 2 most common histologies are squamous cell carcinoma and adenocarcinoma, which has seen an increase in incidence correlating with an increase in obesity in developed countries. Gastroesophageal adenocarcinoma has a preponderance to metastasize early, making it a highly lethal cancer with a low 5-year survival rate of similar to 15-25%. Therefore, for the majority of patients, treatment focuses on palliation and prolongation of survival. Combination chemotherapy regimens, mostly platinum-based, have only

APA, Harvard, Vancouver, ISO, and other styles

13

Forsyth, Leigh James. "Identification of DNA sequences involved in the metastatic phenotype of human prostatic carcinoma cells." Thesis, University of Liverpool, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269601.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Dhanda, Jagtar. "Molecular indicators and tumour models of extracapsular spread in metastatic oral squamous cell carcinoma." Thesis, University of Liverpool, 2014. http://livrepository.liverpool.ac.uk/19295/.

Full text

Abstract:

Introduction Extracapsular spread (ECS) is the single most adverse prognosticator for recurrence and death in metastatic oral squamous cell carcinoma (OSCC) and relapse is common in both primary and metastatic sites. It is rarely exploited for biological investigation with limited study of its molecular determinants and the absence of a tumour model. The absence of a biomarker also means exhaustive histological examination after surgery is required for diagnosis. ECS is a late manifestation of the metastatic cascade and would be expected to be intimately related to interactions between tumour

APA, Harvard, Vancouver, ISO, and other styles

15

Kelly, Stephen Richard. "The expression of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in metastatic colorectal carcinoma (CRC)." Thesis, University of Southampton, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.412204.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Yau, Wing-lung, and 邱泳龍. "Identification of miR-106b over-expression in metastatic hepatocellular carcinoma by using the orthotopic animal model." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B45204032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Land, Walker, Dan Margolis, Ronald Gottlieb, Elizabeth Krupinski, and Jack Yang. "Improving CT prediction of treatment response in patients with metastatic colorectal carcinoma using statistical learning theory." BioMed Central, 2010. http://hdl.handle.net/10150/610011.

Full text

Abstract:

BACKGROUND:Significant interest exists in establishing radiologic imaging as a valid biomarker for assessing the response of cancer to a variety of treatments. To address this problem, we have chosen to study patients with metastatic colorectal carcinoma to learn whether statistical learning theory can improve the performance of radiologists using CT in predicting patient treatment response to therapy compared with the more traditional RECIST (Response Evaluation Criteria in Solid Tumors) standard.RESULTS:Predictions of survival after 8 months in 38 patients with metastatic colorectal carcinom

APA, Harvard, Vancouver, ISO, and other styles

18

Pierobon, Elisa Sefora/ES. "TRATTAMENTO ABLATIVO CON MICROONDE DI METASTASI EPATICHE DA TUMORE DELLA MAMMELLA: STUDIO DI FATTIBILITÀ ED EFFICACIA." Doctoral thesis, Università degli studi di Padova, 2017. http://hdl.handle.net/11577/3426792.

Full text

Abstract:

INTRODUCTION Prognosis of patients with breast cancer liver metastases is still dismal. Some retrospective data support adjuvant surgery in selected patients. Ablative treatment in the management of breast cancer liver metastases remains controversial. MATERIAL AND METHODS We evaluated the efficacy (complete ablation and recurrence rate) and the safety (morbidity and mortality) of the microwave ablation treatment (MWA) of breast cancer liver metastases, performed in our Center from 2009 to 2016. Analysis was performed on a nodule-oriented and patient-oriented base. RESULTS Median t

APA, Harvard, Vancouver, ISO, and other styles

19

Minata, Mutsuko. "Postoperative detection of α-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma". Kyoto University, 2002. http://hdl.handle.net/2433/149325.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Sharma, Purva, James Kim, Devapiran Jaishankar, and Sakshi Singal. "EXTENDED PROGRESSION-FREE SURVIVAL ON FIRST LINE TREATMENT WITH DOCETAXEL IN PATIENT WITH METASTATIC TRIPLE NEGATIVE BREAST CARCINOMA." Digital Commons @ East Tennessee State University, 2021. https://dc.etsu.edu/asrf/2021/presentations/43.

Full text

Abstract:

Docetaxel is a chemotherapeutic agent in the taxane group of drugs which is commonly used in the first line setting for metastatic hormone receptor negative breast cancer. We present a case of a 46 year old female who was diagnosed with de novo triple negative metastatic breast carcinoma, and has had an extended progression free survival (PFS) of almost 5 years on first line single agent treatment with Docetaxel. 46 year old female presented with a large left breast mass as well as axillary mass which revealed grade 3 invasive ductal carcinoma of breast on biopsy of both sites. Tumor was estro

APA, Harvard, Vancouver, ISO, and other styles

21

Xu, Wei. "Cytogenetic analysis of a murine mammary carcinoma in vitro and during progression from primary to metastatic growth in vivo." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq20717.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Shestowsky, William S. "Production and characterization of a monoclonal antibody to a highly metastatic and organ-selective variant of the Lewis lung carcinoma." Thesis, McGill University, 1988. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=61747.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Vinayan, Anup. "Targeted anti-angiogenic therapy in metastatic renal cell carcinoma and methodological improvements in assessment of therapeutic response with imaging biomarkers." Thesis, University of Hertfordshire, 2018. http://hdl.handle.net/2299/20960.

Full text

Abstract:

Background: Drugs targeting angiogenic pathway remain the mainstay of treatment for metastatic renal cell carcinoma (mRCC). Tyrosine Kinase Inhibitors (TKI) as Sunitinib, Pazopanib as single agents and humanised monoclonal antibody bevacizumab (Bev) in combination with Interferon- α2a (IFN) have established as the first-line therapy for mRCC. Despite improvements in treatment, there are multiple questions which remain unanswered. In the combination of Bev and IFN, the respective role of each drug and whether any additional anti-angiogenic activity is gained by adding IFN to Bev remains unknown

APA, Harvard, Vancouver, ISO, and other styles

24

Kale, Hrishikesh P. "Economic Burden of Renal Cell Carcinoma (RCC) and Treatment Patterns, Overall Survival and Healthcare Costs among Older Metastatic RCC Patients." VCU Scholars Compass, 2018. https://scholarscompass.vcu.edu/etd/5555.

Full text

Abstract:

Background Renal cell carcinoma (RCC) is the most common type of kidney cancer. Patients diagnosed with metastatic RCC (mRCC) have shorter overall survival compared to those diagnosed at earlier stages. Several targeted therapies, which cost from $7,000 - $16,000 per month have been approved since 2005 to treat mRCC. In addition, there is a growing interest in the use of cytoreductive nephrectomy (CN) with targeted therapies among mRCC patients. However, little is known regarding the economic burden of RCC and role of CN and prescribing patterns of targeted therapies among older mRCC patients.

APA, Harvard, Vancouver, ISO, and other styles

25

CIMADAMORE, ALESSIA. "Biomarkers of angiogenesis and clinical outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Randomized Phase III METEOR Trial." Doctoral thesis, Università Politecnica delle Marche, 2022. https://hdl.handle.net/11566/295826.

Full text

Abstract:

Gli inibitori del recettore anti-angiogenico VEGF (VEGFR) sono stati approvati per il trattamento di pazienti con carcinoma renale (RCC) metastatico e la loro efficacia è maggiore nei tumori con elevata angiogenesi. Dato che Cabozantinib inibisce multipli recettori tirosin-chinasici, incluso VEGFR, l'obiettivo dello studio è quello di valutare se marcatori di angiogenesi, ovvero la densità microvascolare (MVD) e la densità dei mastociti (MCD), sono predittivi di risposta alla terapia con cabozantinib versus everolimus. Sono stati utilizzati campioni istologici di carcinomi renali di pazienti a

APA, Harvard, Vancouver, ISO, and other styles

26

Wu, Rita Shiu-fung. "Effects of B7.1, IFN-gamma, and antisense TGF-beta gene transfer on the tumorigenicity of murine 4T1 metastatic mammary carcinoma cells." Diss., The University of Arizona, 2001. http://hdl.handle.net/10150/280475.

Full text

Abstract:

Cancer progression is attributed in part to immune evasion strategies that include lack of co-stimulation, down-regulation of cell surface MHC molecules, and secretion of immunosuppressive factors such as transforming growth factor-β (TGF-β). Gene therapy has been employed to counter these mechanisms of immune evasion by transference of B7.1, IFN-γ or antisense TGF-β genes into tumor cells resulting in cell surface expression of B7.1, upregulation of MHC class I and class II molecules, or elimination tumor-derived TGF-β, respectively. Although each of these transgenes has been shown to alter t

APA, Harvard, Vancouver, ISO, and other styles

27

Hall, Charles. "Ex vivo reprogramming of tumor-reactive immune cells from FVBN202 mice bearing lung metastatic mammary carcinoma: an immunotherapeutic opportunity revealed against recurrence." VCU Scholars Compass, 2013. http://scholarscompass.vcu.edu/etd/3176.

Full text

Abstract:

Metastatic breast cancer treatment has seen few advances in recent years, yet treatment resistance continues to rise, causing disease recurrence. A pilot study was performed to determine the efficacy of ex vivo expansion and reprogramming of tumor-reactive immune cells from experimental metastatic tumor-sensitized mice. Also, phenotypic changes in tumors due to metastasis or tumor microenvironment influences were characterized. Metastatic neu+ mouse mammary carcinoma (mMMC) and its distant relapsing neu-antigen-negative variant (mANV) were investigated in FVBN202 mice. Tumor-reactive central m

APA, Harvard, Vancouver, ISO, and other styles

28

Duffie, Gordon Patrick. "Tumoricidal activity of pulmonary alveolar macrophages isolated from C57BL/6 mice bearing either a cloned metastatic or nonmetastatic variant of Lewis lung carcinoma." Virtual Press, 1988. http://liblink.bsu.edu/uhtbin/catkey/558376.

Full text

Abstract:

The spontaneous tumoricidal ability of pulmonary alveolar macrophages (PAM) isolated from C57B1/6 mice bearing either a metastatic or a nonmetastatic cloned variant of Lewis lung carcinoma (LLC) was examined in vitro. During the early weeks of tumor development the cytotoxicity mediated by macrophages was enhanced in the tumor-bearing mice, especially in the metastatic tumor bearers. Later in tumor progress (week 4) the spontaneous cytotoxicity of both groups typically declined to levels less than those of normal macrophages. Experiments were performed to determine if macrophages could be acti

APA, Harvard, Vancouver, ISO, and other styles

29

Raposo-Ferreira, Talita Mariana Morata [UNESP]. "Estudo em larga escala da expressão gênica de carcinomas mamários em cadelas." Universidade Estadual Paulista (UNESP), 2016. http://hdl.handle.net/11449/143484.

Full text

Abstract:

Submitted by Talita Mariana Morata Raposo null (talita_raposo@yahoo.com.br) on 2016-08-26T23:53:52Z No. of bitstreams: 1 tese.pdf: 7349096 bytes, checksum: 15c4a9aa3753843c66b8604dad27c6e8 (MD5)<br>Approved for entry into archive by Ana Paula Grisoto (grisotoana@reitoria.unesp.br) on 2016-08-30T18:12:04Z (GMT) No. of bitstreams: 1 ferreira_tmmr_dr_jabo.pdf: 7349096 bytes, checksum: 15c4a9aa3753843c66b8604dad27c6e8 (MD5)<br>Made available in DSpace on 2016-08-30T18:12:04Z (GMT). No. of bitstreams: 1 ferreira_tmmr_dr_jabo.pdf: 7349096 bytes, checksum: 15c4a9aa3753843c66b8604dad27c6e8 (MD5)

APA, Harvard, Vancouver, ISO, and other styles

30

Gagno, Sara. "Innovative strategies for tailoring therapy in cancer patient: pharmacogenetics and hormone therapy personalization in metastatic or locally advanced breast cancer patients treated with Exemestane." Doctoral thesis, Università degli studi di Padova, 2015. http://hdl.handle.net/11577/3423964.

Full text

Abstract:

Background: Response to chemotherapeutic agents is highly variable among patients both in terms of efficacy and tolerability; consequently personalization of drug therapy is one of the main objective in cancer treatment in order to reduce adverse drug reactions (ADRs), improve efficacy while decreasing the costs of treatments. Many factors account for inter-individual differences. Among them, patient’s genetic background has attracted interest for personalization of drug therapy (Pharmacogenetics). Breast cancer (BC) is the female most frequently diagnosed malignancy and the primary cause of

APA, Harvard, Vancouver, ISO, and other styles

31

Miller, Kurt, Rudolf Morant, Arnulf Stenzl, Manfred P. Wirth, and Ivan Zuna. "A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium." Karger, 2016. https://tud.qucosa.de/id/qucosa%3A70589.

Full text

Abstract:

Introduction: This phase II trial evaluated the efficacy and safety of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, gefitinib, in combination with first-line chemotherapy in advanced urothelial cancer. Methods: Chemotherapy-naïve patients with advanced or metastatic urothelial carcinoma were randomized 1:1:1 to receive six cycles of chemotherapy (gemcitabine 1,250 mg/m 2 on days 1 and 8, and cisplatin 70 mg/m 2 on day 1 of every cycle) concomitantly with gefitinib 250 mg/day (arm A); or with sequential gefitinib (arm B); or alone (arm C). The primary endpoint was the

APA, Harvard, Vancouver, ISO, and other styles

32

Pretscher, Dominik. "Distribution of immune cells in head and neck cancer : CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma." kostenfrei, 2010. http://d-nb.info/1000329054/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Ostheimer, Christian Emil Arthur Verfasser], Dirk [Akademischer Betreuer] Vordermark, Bernd [Akademischer Betreuer] Schmidt, and Daniel [Akademischer Betreuer] [Zips. "Prognostic and predictive significance of osteopontin and other hypoxia-related plasma proteins in the radiotherapy of locally advanced and metastatic bronchial carcinoma / Christian Emil Arthur Ostheimer. Betreuer: Dirk Vordermark ; Bernd Schmidt ; Daniel Zips." Halle, Saale : Universitäts- und Landesbibliothek Sachsen-Anhalt, 2015. http://d-nb.info/1089085419/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Kwok, Mon-sze. "Study of metastatic suppressing genes on ovarian carcinomas /." View the Table of Contents & Abstract, 2006. http://sunzi.lib.hku.hk/hkuto/record/B36586328.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Kwok, Mon-sze, and 郭夢思. "Study of metastatic suppressing genes on ovarian carcinomas." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B45010729.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

LeBedis, Christina. "Lymph node involvement in breast carcinoma metastasis." Thesis, McGill University, 2000. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=31255.

Full text

Abstract:

Since lymph node stromal cells remain largely uncharacterized with respect to cell surface markers and function, their role in regulating the growth and invasion of disseminated cancer cells, including breast carcinoma has, to date, been virtually unexplored. In the present study, we asked whether peripheral lymph node cells could modulate the growth of breast carcinoma cells and, thereby, contribute to the progression of the metastatic process. Primary cultures of rat peripheral lymph node stromal cells were obtained by limiting dilution and two sublines, STA4 and STB12, with breast carcinoma

APA, Harvard, Vancouver, ISO, and other styles

37

吳曉靑 and Xiaoqing Wu. "Post-radiotherapy cervical metastasis in nasopharyngeal carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1999. http://hub.hku.hk/bib/B31222018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Wu, Xiaoqing. "Post-radiotherapy cervical metastasis in nasopharyngeal carcinoma /." Hong Kong : University of Hong Kong, 1999. http://sunzi.lib.hku.hk/hkuto/record.jsp?B20843252.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Silva, Maria João da Costa Soares da. "Clinical and molecular characterization of feline mammary carcinomas overexpressing HER2 proto-oncogene (FMC-HER2+) : new strategies for effective diagnostic and cancer therapy." Doctoral thesis, Universidade de Lisboa, Faculdade de Medicina Veterinária, 2016. http://hdl.handle.net/10400.5/12008.

Full text

Abstract:

Tese de Doutoramento em Ciências Veterinárias na Especialidade de Ciências Biológicas e Biomédicas<br>mariajosoares@gmail.com<br>Considering the scarce data available in feline mammary carcinoma (FMC) and despite its importance in veterinary clinical practice, this thesis emerges in order to increase the knowledge of this tumor type, especially the FMC-HER2 positive. In the first two studies, the protocols for detection and quantification of the fHER2 and Ki-67 biomarkers were optimized and validated. These studies demonstrated that, in cats, the incidence of fHER2 overexpression were similar

APA, Harvard, Vancouver, ISO, and other styles

40

Clark, Richard R. "Lymph node metastasis in auricular squamous cell carcinoma." Thesis, University of Glasgow, 2009. http://theses.gla.ac.uk/547/.

Full text

Abstract:

Introduction Squamous cell carcinoma of the auricle has an unusually high rate of lymph node metastases when compared to similar tumours at other sites. The lymph nodes affected are close to the base of the skull and in the neck. Development of metastasis carries a poor prognosis and most patients will subsequently die of failure of loco-regional control. Despite the likelihood of a poor outcome nothing can be done for patients prior to development of metastasis, as the risk of spread is not sufficiently high to warrant intervention in all patients. They are therefore treated with a ‘wait and

APA, Harvard, Vancouver, ISO, and other styles

41

BIANCONI, MARISTELLA. "Il profilo angiogenico nel carcinoma renale metastatico: implicazioni prognostiche e terapeutiche." Doctoral thesis, Università Politecnica delle Marche, 2018. http://hdl.handle.net/11566/253118.

Full text

Abstract:

Il trattamento del carcinoma renale avanzato è radicalmente cambiato nell’ultimo decennio. Le opzioni disponibili sono per la maggior parte dirette contro la via dell’angiogenesi. Nonostante questo i pazienti trattati sperimentano outcome molto diversi tra di loro e, al momento, non possediamo fattori predittivi. Sulla scorta delle nostre precedenti analisi dei polimorfismi di VEGF e VEGFR nel carcinoma renale avanzato in pazienti trattati in prima linea con sunitinib o pazopanib, abbiamo voluto analizzare l’eventuale influenza di tali polimorfismi per quanto concerne la seconda linea. Dei p

APA, Harvard, Vancouver, ISO, and other styles

42

Yuen, Po-wing. "The study of nodal metastasis of oral tongue carcinoma." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B39793837.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Ip, Ying-chi. "MT1-MMP in relation to metastasis of hepatocellular carcinoma." Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/B31490189.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Haq, Mahmudul. "Host-tumor interactions in skeletal metastasis of prostate carcinoma." Thesis, McGill University, 1992. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=56996.

Full text

Abstract:

Approximately 70% of patients with prostatic cancer develop bone metastases. Metastatic prostate adenocarcinomas are associated with high mortality rates and represent a leading cause of cancer-related deaths among males. To study the host-tumor interactions underlying the predilection of prostate cancer cells for skeletal bone, an experimental model was developed using rat Dunning carcinoma Mat-LyLu cells. Inoculations of these cells into the left ventricle of the heart led to the development of spinal metastases in 100% of inoculated animals. A subline of Mat-LyLu (Mat-LyLu-B5) was subsequen

APA, Harvard, Vancouver, ISO, and other styles

45

韋霖 and William I. Wei. "Surgery for post-radiotherapy cervical metastasis in nasopharyngeal carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1991. http://hub.hku.hk/bib/B31979543.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Ip, Ying-chi, and 葉瑩芝. "MT1-MMP in relation to metastasis of hepatocellular carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B31490189.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Yuen, Po-wing, and 袁寶榮. "The study of nodal metastasis of oral tongue carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B39793837.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Volk, Andreas, Stephan Kersting, Ralf Konopke, et al. "Surgical Therapy of Intrapancreatic Metastasis from Renal Cell Carcinoma." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-136489.

Full text

Abstract:

Background: Pancreatic métastases from renal cell carcinoma (RCC) are clinically rare but highly resectable. The aim of this article is to identify patients who profit from pancreatic resection of RCC despite the invasiveness of the surgery. Methods: Between January 1996 and December 2007, data from 744 patients were collected in a prospective pancreatic surgery database, and patients with metastasis into the pancreas from RCC were identified. Results: Resective surgery was performed in 14 patients with metastasis to the pancreas from RCC. Most patients were clinically asymptomatic. The median

APA, Harvard, Vancouver, ISO, and other styles

49

Volk, Andreas, Stephan Kersting, Ralf Konopke, et al. "Surgical Therapy of Intrapancreatic Metastasis from Renal Cell Carcinoma." Karger, 2009. https://tud.qucosa.de/id/qucosa%3A27708.

Full text

Abstract:

Background: Pancreatic métastases from renal cell carcinoma (RCC) are clinically rare but highly resectable. The aim of this article is to identify patients who profit from pancreatic resection of RCC despite the invasiveness of the surgery. Methods: Between January 1996 and December 2007, data from 744 patients were collected in a prospective pancreatic surgery database, and patients with metastasis into the pancreas from RCC were identified. Results: Resective surgery was performed in 14 patients with metastasis to the pancreas from RCC. Most patients were clinically asymptomatic. The median

APA, Harvard, Vancouver, ISO, and other styles

50

GIACOBBE, ARIANNA. "Two novel p63 transcriptional target genes regulating cell metabolism and metastasis." Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2014. http://hdl.handle.net/2108/204221.

Full text

Abstract:

La famiglia di p53, costituita dai tre fattori di trascrizione p53, p63 e p73, assume un ruolo chiave nel direzionare il destino di una cellula verso la sopravvivenza o attivando meccanismi di morte cellulare programmata. Sebbene la loro struttura genica sia simile, p63 e p73 codificano per varie isoforme generate a partire da promotori diversi all’estremità 5’ e da meccanismi di splicing alternativo al 3’, a seguito del quale derivano isoforme TA complete del dominio di trans-attivazione all’N-terminale o isoforme tronche denominate ΔN. Il capostipite della famiglia, p53, è principalmente des

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!